Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2025-01-22 Director's Dealing
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 3 pages 172.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares and options acquired and disposed, nature of interest, and dates of changes. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is not an announcement of a report, nor a full financial report, but a specific regulatory filing about director share transactions.
2025-01-22 English
Nanoveu Advances EMASS Technology Acquisition 2 pages 212.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 22 January 2025 announcing the progress and imminent completion of an acquisition of EMASS by Nanoveu Limited. It details the due diligence completion, shareholder approval, and strategic significance of the acquisition. There are no financial statements or detailed financial performance data included. The document is a corporate announcement about a capital transaction (acquisition) rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 5303 characters, which is sufficient for a detailed announcement but does not contain financial statements or results. Hence, the classification is CAP with high confidence.
2025-01-21 English
Application for quotation of securities - NVU 6 pages 18.5KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from Nanoveu Limited regarding the application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, and related information. This is a formal regulatory announcement related to the listing or quotation of securities rather than a financial report, earnings release, or management discussion. It is not a report itself but an application/announcement for quotation of securities, which aligns with capital or financing updates. Given the nature of the document, it fits best under the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about securities issuance and quotation, not just a brief notice or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2025-01-21 English
Notification regarding unquoted securities - NVU 5 pages 17.0KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities by Nanoveu Limited. It includes specifics such as security codes, issue dates, and quantities. The document is a formal notification about securities issuance, referencing a previous Appendix 3B announcement. It does not contain financial statements, management discussion, or earnings data. It is not an annual or interim report, nor a call transcript or governance document. The content fits the category of announcements regarding new share issues or capital changes. Therefore, the document is best classified as a Share Issue/Capital Change announcement (SHA). The document length (5512 characters) and detailed issuance data support this classification with high confidence.
2025-01-21 English
EMASS Achieves Ultra-Low Power Fall Detection with ECS Chip 4 pages 424.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 15 January 2025 from Nanoveu Limited announcing the successful results of the EMASS ECS-Dot Chipset in fall detection technology. It focuses on product performance highlights, technical details, market potential, and future plans. There are no financial statements, no regulatory certifications, no voting results, no management or board changes, no merger or acquisition activity, and no mention of quarterly or annual financial results. The document is a corporate announcement about a technology demonstration and product update. It is not a financial report, earnings release, or regulatory filing. Given the content and context, the document fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement and corporate update that does not fit into any other specific category.
2025-01-14 English
Notification of cessation of securities - NVU 4 pages 14.9KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (options) for Nanoveu Limited, including the number of securities ceased, reasons for cessation, and updated issued capital figures. It is a regulatory announcement about changes in the company's issued capital related to securities that have expired or ceased. The document is short (4244 characters) and is a formal notification to the ASX about securities cessation, not a financial report or detailed analysis. This fits the category of Share Issue/Capital Change announcements, which cover new share issues, stock splits, or other capital changes including cessation of securities.
2025-01-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.